CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo

Journal of Clinical Investigation

Volumn 105, Issue 10, 2000, Pages 1395-1406

  Passier, Robert ^a   Zeng, Hong ^b   Frey, Norbert ^a   Naya, Francisco J ^a   Nicol, Rebekka L ^a   McKinsey, Timothy A ^a   Overbeek, Paul ^c   Richardson, James A ^d   Grant, Stephen R ^b   Olson, Eric N ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE (CALCIUM,CALMODULIN) I; PROTEIN KINASE (CALCIUM,CALMODULIN) IV; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 19244386873     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI8551     Document Type: Article

References (71)

1. McKinsey, T.A., and Olson, E.N. 1999. Cardiac hypertrophy: sorting out the circuitry. Curr. Opin. Genet. Dev. 9:267-274.
2. Sadoshima, J., and Izumo, S. 1997. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59:551-571.
3. Chien, K.R. 1999. Stress pathways and heart failure. Cell. 98:555-558.
4. MacLellan, W.R., and Schneider, M.D. 1998. Success in failure: modeling cardiac decompensation in transgenic mice. Circulation. 97:1433-1435.
5. Sei, C.A., et al. 1991. The α-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways. J. Biol. Chem. 266:15910-15916.
6. Sonnenberg, H. 1986. Mechanisms of release and renal tubular action of atrial natriuretic factor. Fed. Proc. 45:2106-2110.
7. LaPointe, M.C., Deschepper, C.F., Wu, J.P., and Gardner, D.G. 1990. Extracellular calcium regulates expression of the gene for atrial natriuretic factor. Hypertension. 15:20-28.
8. Karliner, J.S., Kariya, T., and Simpson, P.C. 1990. Effects of pertussis toxin on α1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat myocytes. Experientia. 46:81-84.
9. Leite, M.F., Page, E., and Ambler, S.K. 1994. Regulation of ANP secretion by endothelin-1 in cultured atrial myocytes: desensitization and receptor subtype. Am. J. Physiol. 267:H2193-H2203.
10. Sadoshima, J., Xu, Y., Slayter, H.S., and Izumo, S. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
11. Schaub, M.C., Hefti, M.A., Zeullig, R.A., and Morano, I. 1998. Modulation or contractility in human cardiac hypertrophy by essential myosin light chain isoforms. Cardiovasc. Res. 37:381-404.
12. Molkentin, J.D., et al. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 17:215-228.
13. Sussman, M.A., et al. 1998. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 281:1690-1693.
14. Mende, U., et al. 1998. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc. Natl. Acad. Sci. USA. 95:13893-13898.
15. Taigen, T., De Windt, L.J., Lim, H.W., and Molkentin, J.D. 2000. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA. 97:1196-1201.
16. Zhang, W., et al. 1999. Failure or calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ. Res. 84:722-728.
17. Ding, B., et al. 1999. Pressure overload induces severe hypertrophy in mice treated with cyclosporin, an inhibitor of calcineurin. Circ. Res. 84:729-734.
18. Meguro, T., et al. 1999. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ. Res. 84:735-740.
19. Luo, Z., Shyu, K.G., Gulaberto, A., and Walsh, K. 1998. Calcineurin inhibitors and cardiac hypertrophy. Nat. Med. 10:1092-1093.
20. Olson, E.N., and Molkentin, J.D. 1999. Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ. Res. 84:623-632.
21. Muller, J.G., Nemoto, S., Laser, M., Carabello, B.A., and Menick, D.R. 1998. Calcineurin inhibition and cardiac hypertrophy [letter]. Science. 282:1007.
22. Shimoyama, M., et al. 1999. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Circulation. 100:2449-2454.
23. Gruver, C.L., DeMayo, F., Goldstein, M.A., and Means, A.R. 1993. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomycytes in transgenic mice. Endocrinology. 133:376-388.
24. 2+/calmodulin-dependenc protein kinase II regulates atrial natriureric factor gene expression in ventricular myocytes. J. Biol. Chem. 272:31203-31208.
25. McDonough, P.M., Stella, S.L., and Glembotski, C.C. 1994. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin. J. Biol. Chem. 269:9466-9472.
26. Irons, C.E., Sei, C.A., Hidaka, H., and Glembotski, C.C. 1992. Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes. J. Biol. Chem. 267:5211-5216.
27. 2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc. Res. 42:254-261.
28. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84:713-721.
29. Black, B., and Olson, E.N. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
30. McBride, K., Robitaille, L., Tremblay, S., Argentin, S., and Nemer, M. 1993. Fos/jun repression of cardiac-specific transcription in quiescent and growth-stimulated myocytes is targeted at a tissue-specific cis element. Mol. Cell. Biol. 13:600-612.
31. MacLellan, W.R., Lee, T., Schwartz, R.J., and Schneider, M.D. 1994. Transforming growth factor-response elements of the skeletal α-actin gene. J. Biol. Chem. 269:16754-16760.
32. Gulick, J., Subramaniam, A., Neumann, J., and Robbins, J. 1991. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J. Biol. Chem. 266:9180-9185.
33. 2+/calmodulin-dependent protein kinase type IV/GR. J. Biol. Chem. 271:21542-21548.
34. Naya, F.J., Wu, C., Richardson, J.A., Overbeek, P., and Olson, E.N. 1999. Transcriptional activity of MEF2 during mouse embryogenesis monitored with a MEF2-dependent transgene. Development. 126:2045-2052.
35. Miller, J.M. 1972. Assays for β-galactosidase. In Molecular genetics. J.M. Miller, editor. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 352-355.
36. Hogan, B., Constanini, F., and Lacy, E. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, New York, USA. 497pp.
37. Gardin, J.M., et al. 1995. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ. Res. 76:907-914.
38. Gossett, L.A., Kelvin, D.J., Sternberg, E.A., and Olson, E.N. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022-5033.
39. Miyano, O., Kameshita, I., and Fujisawa, H. 1992. Purification and characterization of a brain-specific multifunctional calmodulin-dependent protein kinase from rat cerebellum. J. Biol. Chem. 267:1198-1203.
40. Devereux, R.B., and Roman, M.J. 1999. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens. Res. 22:1-9.
41. Lin, Q., Schwarz, J., Buchana, C., and Olson, E.N. 1997. Control of cardiac morphogenesis and myogenesis by the myogenic transcription factor MEF2C. Science. 276:1404-1407.
42. Yu, Y.T., et al. 1992. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 6:1783-1798.
43. Breitbart, R.E., et al. 1993. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development. 118:1095-1106.
44. 2+ response amplitude and duration. Nature. 386:855-858.
45. McDonough, P.M., and Glembotski, C.C. 1992. Induction of atrial natriuretic factor and myosin light chain-2 gene expression in cultured ventricular myocytes by electrical stimulation of contraction. J. Biol. Chem. 267:11665-11668.
46. 2+/calmodulin kinase type IV. J. Exp. Med. 184:101-112.
47. 2+/calmodulin kinase type IV/Gr and calcineurin. J. Immunol. 162:2057-2063.
48. Wu, H., et al. 2000. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. In press.
49. Kolodziejczyk, S.M., et al. 1999. MEF2 is upregulated during cardiac hypertrophy and is required for normal pose-natal growth of the myocardium. Curr. Biol. 9:1203-1206.
50. Chin, E.R., et al. 1998. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 15:2499-2509.
51. Sadoshima, J., and Izumo, S. 1993. Signal-transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro. Circ. Res. 73:424-438.
52. Karns, L.R., Kariya, K., and Simpson, P.C. 1995. M-CAT, CArG, and Sp1 elements are required for α1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. J. Biol. Chem. 270:410-417.
53. Kovacic-Milivojevic, B., Wong, V.S.H., and Gardner, D.G. 1996. Selective regulation of the atrial natriuretic peptide gene by individual components of the activator protein-1 complex. Endocrinology. 137:1108-1117.
54. Paradis, P., MacLellan, W.R., Belaguli, N.S., Schwartz, R.J., and Schneider, M.D. 1996. Serum response factor mediates AP-1-dependent induction of the skeletal α-actin promoter in ventricular myocytes. J. Biol. Chem. 271:10827-10833.
55. Herzig, T.C., et al. 1997. Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA-4 mediate the response to pressure overload. Proc. Natl. Acad. Sci. USA. 94:7543-7548.
56. Hasegawam, K., Lee, S.J., Jobe, S.M., Markham, B.E., and Kitsis, R.N. 1997. Cis-acting sequences that mediate induction of the α-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation. 96:3943-3953.
57. Lin, Q., et al. 1998. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development. 125:4565-4574.
58. 2+/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem. 273-.31880-31889.
59. 2+/calmodulin-dependent protein kinase IV expressed in insect cells. J. Biol. Chem. 268:26171-26178.
60. Braun, A.P., and Schulman, H. 1995. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu. Rev. Physiol. 57:417-445.
61. Mao, Z., and Weidmann, M. 1999. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J. Biol. Chem. 274:31102-31107.
62. Naya, J.F., and Olson, E.N. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 11:683-688.
63. Lu, J., McKinsey, T.A., Nicol, R.L., and Olson, E.N. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from historic deacetylases. Proc. Natl. Acad. Sci. USA. 97:4070-4075.
64. Blaeser, F., Ho, N., Prywes, R., and Chatila, T.A. 2000. Ca2+-dependent gene expression mediated by MEF2 transcription factors. J. Biol. Chem. 275:197-209.
65. 2+/calmodulin-dependent protein kinase type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8:2527-2539.
66. Matthews, R.P., et al. 1994. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol. 14:6107-6116.
67. Fentzke, R.C., Korcarz, C.E., Lang, R.M., Lin, H., and Leiden, J.M. 1998. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J. Clin. Invest. 101:2415-2426.
68. Witcher, D.R., Kovacs, R.J., Schulman, H., Cefali, D.C., and Jones, L.R. 1991. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 266:11144-11152.
69. 2+/calmodulin-dependent protein kinase. J. Biol. Chem. 264:8394-8397.
70. Simmerman, H.K., Collins, J.H., Theibert, L.J., Wegener, A.D., and Jones, L.R. 1986. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J. Biol. Chem. 261:13333-13341.
71. 2+/calmodulin-dependent protein kinase II. Biochem. Biophys. Res. Commun. 254:699-702.